207 related articles for article (PubMed ID: 32758351)
21. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
22. Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes.
Febvre-James M; Lecureur V; Fardel O
Inflamm Res; 2020 Jan; 69(1):51-62. PubMed ID: 31654094
[TBL] [Abstract][Full Text] [Related]
23. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
[TBL] [Abstract][Full Text] [Related]
24. Granulosa cells from human primordial and primary follicles show differential global gene expression profiles.
Ernst EH; Franks S; Hardy K; Villesen P; Lykke-Hartmann K
Hum Reprod; 2018 Apr; 33(4):666-679. PubMed ID: 29506120
[TBL] [Abstract][Full Text] [Related]
25. JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts.
Sun L; Ma K; Wang H; Xiao F; Gao Y; Zhang W; Wang K; Gao X; Ip N; Wu Z
J Cell Biol; 2007 Oct; 179(1):129-38. PubMed ID: 17908914
[TBL] [Abstract][Full Text] [Related]
26. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
Hermans MAW; Schrijver B; van Holten-Neelen CCPA; Gerth van Wijk R; van Hagen PM; van Daele PLA; Dik WA
Clin Exp Allergy; 2018 Nov; 48(11):1412-1420. PubMed ID: 29939445
[TBL] [Abstract][Full Text] [Related]
27. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
[TBL] [Abstract][Full Text] [Related]
28. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.
Campia I; Buondonno I; Castella B; Rolando B; Kopecka J; Gazzano E; Ghigo D; Riganti C
PLoS One; 2015; 10(5):e0126159. PubMed ID: 25955018
[TBL] [Abstract][Full Text] [Related]
29. Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma.
Yang S; Luo C; Gu Q; Xu Q; Wang G; Sun H; Qian Z; Tan Y; Qin Y; Shen Y; Xu X; Chen SH; Chan CC; Wang H; Mao M; Fang DD
Oncotarget; 2016 Feb; 7(5):5461-9. PubMed ID: 26701727
[TBL] [Abstract][Full Text] [Related]
30. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
31. Depletion of cellular glutathione modulates LIF-induced JAK1-STAT3 signaling in cardiac myocytes.
Kurdi M; Sivakumaran V; Duhé RJ; Aon MA; Paolocci N; Booz GW
Int J Biochem Cell Biol; 2012 Dec; 44(12):2106-15. PubMed ID: 22939972
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of JAK-STAT Signaling by Baricitinib Reduces Interferon-γ-Induced CXCL10 Production in Human Salivary Gland Ductal Cells.
Aota K; Yamanoi T; Kani K; Ono S; Momota Y; Azuma M
Inflammation; 2021 Feb; 44(1):206-216. PubMed ID: 32772240
[TBL] [Abstract][Full Text] [Related]
33. PRR34-AS1 overexpression promotes protection of propofol pretreatment against ischemia/reperfusion injury in a mouse model after total knee arthroplasty via blockade of the JAK1-dependent JAK-STAT signaling pathway.
Fang H; Zhang FX; Li HF; Yang M; Liao R; Wang RR; Wang QY; Zheng PC; Zhang JP
J Cell Physiol; 2020 Mar; 235(3):2545-2556. PubMed ID: 31556112
[TBL] [Abstract][Full Text] [Related]
34. JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy.
Tao J; Mariani L; Eddy S; Maecker H; Kambham N; Mehta K; Hartman J; Wang W; Kretzler M; Lafayette RA
Clin J Am Soc Nephrol; 2020 Jul; 15(7):973-982. PubMed ID: 32354727
[TBL] [Abstract][Full Text] [Related]
35. Effects of propofol on myocardial ischemia reperfusion injury through inhibiting the JAK/STAT pathway.
Zhang WY; Zhang QL; Xu MJ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6339-6345. PubMed ID: 31364141
[TBL] [Abstract][Full Text] [Related]
36. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
37. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
38. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
39. Progesterone activates Janus Kinase 1/2 and activators of transcription 1 (JAK1-2/STAT1) pathway in human spermatozoa.
Sagare-Patil V; Modi D
Andrologia; 2013 Jun; 45(3):178-86. PubMed ID: 22748021
[TBL] [Abstract][Full Text] [Related]
40. A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis.
De Wilde K; Martens A; Lambrecht S; Jacques P; Drennan MB; Debusschere K; Govindarajan S; Coudenys J; Verheugen E; Windels F; Catrysse L; Lories R; McGonagle D; Beyaert R; van Loo G; Elewaut D
Ann Rheum Dis; 2017 Mar; 76(3):585-592. PubMed ID: 27551052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
